Glaucoma Surgery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Glaucoma Surgery Devices Market Insights & Trends and the market is segmented by Product (Glaucoma Drainage Device, Laser System, Punches, Probes, and Others), Surgery Method (Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Glaucoma Surgery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Glaucoma Surgery Devices Market Size

Glaucoma Surgery Devices Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Glaucoma Surgery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Glaucoma Surgery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Glaucoma Surgery Devices Market Analysis

The Glaucoma Surgery Devices Market is expected to register a CAGR of 6.5% during the forecast period.

COVID-19 had a profound impact on the glaucoma surgery devices market owing to the cancellations of elective procedures, including glaucoma surgery. For instance, an article published in the International Ophthalmology Journal in April 2022 stated that the surgical volume of glaucoma dropped by 30.1% at the tertiary glaucoma center of the University Hospital of Verona, Italy, in 2020. The study also mentioned a decline in Baerveldt tube implants of 4.9%. General anesthesia was used for just 24.3% of the surgeries, as compared to 41.5% in the pre-pandemic period. However, the market has been recovering well over the last two years since the restrictions were lifted. The rise in glaucoma surgeries worldwide to clear the backlogs of surgical procedures caused by the pandemic restrictions compensated for the market growth in the later phase of the pandemic. The rising awareness about glaucoma treatment and prevention worldwide in recent times is adding to the market's growth. For instance, a Glaucoma Awareness Walk was conducted by the newly established Dr. B. R. Ambedkar State Institute of Medical Sciences, Mohali, in March 2022 for the first time to spread awareness related to the disease's prevention and treatment options. The awareness campaign reported that in India, every eighth individual, or nearly 40 million people, has either glaucoma or is at risk of developing the disease, and 11.2 million Indians suffer from the disease, with 1.1 million being blind, including children. Therefore, the high burden of the disease is anticipated to boost the utility of glaucoma surgery devices during the forecast years.

In addition, the rising prevalence of glaucoma, the increasing geriatric population, and the growing adoption of surgical treatments for glaucoma are actively affecting the growth of the studied market.

According to the 2022 update from the World Glaucoma Association (WGA), 79.6 million people worldwide were predicted to have glaucoma in 2020. It was estimated that there would be 111.8 million people with glaucoma by 2040. It also stated that at least half of glaucoma patients are unaware of their condition.90% of glaucoma cases in some developing countries go undetected. Thus, the surge in glaucoma is associated with the rise in glaucoma surgery, which is ultimately projected to boost the glaucoma surgery device market.

Also, according to the World Population Prospect 2022 report, the population aged 65 years and over in Sub-Saharan Africa is predicted to be 3.0% in 2022 and projected to reach 3.3% by 2030; in Northern Africa and Western Asia, it is predicted to be 5.5% in 2022 and projected to reach 7.0% by 2030; in Central and Southern Asia, it is estimated to be 6.4% in 2022 and projected to reach 8.1% by 2030; and in Europe and Northern America, it is estimated to be 18.7% in 2022 and projected to reach 22.0% by 2030. Since glaucoma is more common in the geriatric population, the growth of the market segment is likely to increase as the population increases.

Furthermore, glaucoma is the most common cause of irreversible blindness. Various national and international organizations are actively involved in spreading awareness regarding management and treatment options. For instance, the WGA and the World Glaucoma Patient Committee (WGPC) collaborated to commemorate World Glaucoma Week (WGW) from March 7 to March 13, 2021, in an effort to increase public awareness of glaucoma on a global level. Such global awareness initiatives are ultimately projected to boost glaucoma surgery worldwide, which in turn is estimated to propel the market's growth.

Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period. However, the availability of alternative treatment methods is likely to impede market growth.

Glaucoma Surgery Devices Industry Overview

The glaucoma surgery devices market is slightly consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold large market shares and are well known. Some key market players are Abbott Laboratories Inc., Lumenis, Alcon, Glaukos Corporation, ASICO, LLC., Katalyst Surgical LLC., Allergan, Ziemer Ophthalmic Systems, and Carl Zeiss Meditec.

Glaucoma Surgery Devices Market Leaders

  1. Alcon Inc.

  2. ASICO, LLC.

  3. Lumenis Be Ltd.

  4. Glaukos Corporation

  5. Topcon Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Glaucoma Surgery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Glaucoma Surgery Devices Market News

  • June 2022: AbbVie announced it would pay USD 60 million for the rights to acquire iSTAR Medical, a Belgian company developing a minimally invasive glaucoma implantable surgery device. In order to market the device in the United States, iSTAR is now enrolling in a premarket approval study. AbbVie is assisting in developing and commercializing the MINIject device until this study is completed.
  • June 2022: Iridex Corporation received regulatory approval to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases in China by its National Medical Products Administration (NMPA).

Glaucoma Surgery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Glaucoma
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Growing Adoption of Surgical Treatments for Glaucoma
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatment Methods
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Glaucoma Drainage Device
    • 5.1.2 Laser system
    • 5.1.3 Punches
    • 5.1.4 Probes
    • 5.1.5 Other Products
  • 5.2 By Surgery Method
    • 5.2.1 Traditional glaucoma surgery
    • 5.2.2 Minimal invasive glaucoma surgery
    • 5.2.3 Laser Surgery
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ophtalmic Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories Inc.
    • 6.1.2 Lumenis
    • 6.1.3 Alcon
    • 6.1.4 Glaukos Corporation
    • 6.1.5 ASICO LLC
    • 6.1.6 Katalyst Surgical LLC
    • 6.1.7 Allergan
    • 6.1.8 Ziemer Ophthalmic Systems
    • 6.1.9 Carl Zeiss Meditec
    • 6.1.10 Altomed
    • 6.1.11 Nova Eye Medical
    • 6.1.12 Johnson and Johnson
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Glaucoma Surgery Devices Industry Segmentation

As per the scope of the report, glaucoma is a type of eye disease that can cause vision loss and blindness by damaging an optic nerve in the eye. Glaucoma surgery devices deal with the treatment of those diseases. The Glaucoma Surgery Devices Market is classified into three regions: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Glaucoma Drainage Device
Laser system
Punches
Probes
Other Products
By Surgery Method Traditional glaucoma surgery
Minimal invasive glaucoma surgery
Laser Surgery
By End User Hospitals
Ophtalmic Clinics
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Glaucoma Surgery Devices Market Research FAQs

What is the current Glaucoma Surgery Devices Market size?

The Glaucoma Surgery Devices Market is projected to register a CAGR of 6.5% during the forecast period (2025-2030)

Who are the key players in Glaucoma Surgery Devices Market?

Alcon Inc., ASICO, LLC., Lumenis Be Ltd., Glaukos Corporation and Topcon Corporation are the major companies operating in the Glaucoma Surgery Devices Market.

Which is the fastest growing region in Glaucoma Surgery Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Glaucoma Surgery Devices Market?

In 2025, the North America accounts for the largest market share in Glaucoma Surgery Devices Market.

What years does this Glaucoma Surgery Devices Market cover?

The report covers the Glaucoma Surgery Devices Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Glaucoma Surgery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Glaucoma Surgery Devices Industry Report

Statistics for the 2025 Glaucoma Surgery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Glaucoma Surgery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.